Impel Pharmaceuticals to Participate in Upcoming Investor
SEATTLE, March 03, 2023 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage
Globe Newswire4-03-2023, 04:03
Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March 4-03-2025, 04:30